bibliographic resource 338513 [br/338513]
https://w3id.org/oc/corpus/br/338513

is a
title
  • Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group
publication date
  • 2005-01-01
contributor
format
identifier
part of